Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Borderline Personality Disorder and Emotion Dysregulation|March 19, 2024
Borderline personality disorder and sexuality: causes and consequences of dissociative symptomsRose Gholami Mazinan, Christina Dudek, Hannah Warkentin, et al.
Behaviour Research and Therapy|December 2, 2022
Association between the behavioral response during social exclusion and recalled childhood maltreatmentBarbara B Barton, Matthias A Reinhard, Stephan Goerigk, et al.
Pharmacopsychiatry|September 21, 2018
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled StudyRebecca Schennach, Michael Riedel, Ilja Spellmann, et al.
Journal of Psychiatric Research|October 19, 2021
Altered immediate behavioral response to partial social exclusion: A cross-diagnostic study in patients with borderline personality disorder and persistent depressive disorderBarbara B Barton, Stephan Goerigk, Torsten Wüstenberg, et al.
Journal of Psychiatric Research|January 15, 2008
SNAP-25 gene polymorphisms and weight gain in schizophrenic patientsRichard Musil, Ilja Spellmann, Michael Riedel, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 19, 2008
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychoticsIlja Spellmann, Norbert Müller, Richard Musil, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 5, 2025
Personalised Speech-Based PTSD Prediction Using Weighted-Instance LearningAlexander Kathan, Shahin Amiriparian, Andreas Triantafyllopoulos, et al.
Frontiers in Psychiatry|March 1, 2017
High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with CelecoxibDaniela Krause, Aye-Mu Myint, Christine Schuett, et al.
Schizophrenia Research|June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatmentNorbert Müller, Daniela Krause, Sandra Dehning, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 4, 2005
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptomsMichael Riedel, Norbert Müller, Martin Strassnig, et al.
Pageof 9